5-AminouracilCAS# 932-52-5 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products

Cas No. | 932-52-5 | SDF | Download SDF |
PubChem ID | 13611 | Appearance | Powder |
Formula | C4H5N3O2 | M.Wt | 127 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-amino-1H-pyrimidine-2,4-dione | ||
SMILES | C1=C(C(=O)NC(=O)N1)N | ||
Standard InChIKey | BISHACNKZIBDFM-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C4H5N3O2/c5-2-1-6-4(9)7-3(2)8/h1H,5H2,(H2,6,7,8,9) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |

5-Aminouracil Dilution Calculator

5-Aminouracil Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 7.874 mL | 39.3701 mL | 78.7402 mL | 157.4803 mL | 196.8504 mL |
5 mM | 1.5748 mL | 7.874 mL | 15.748 mL | 31.4961 mL | 39.3701 mL |
10 mM | 0.7874 mL | 3.937 mL | 7.874 mL | 15.748 mL | 19.685 mL |
50 mM | 0.1575 mL | 0.7874 mL | 1.5748 mL | 3.1496 mL | 3.937 mL |
100 mM | 0.0787 mL | 0.3937 mL | 0.7874 mL | 1.5748 mL | 1.9685 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland

TsingHua University

The University of Michigan

Miami University

DRURY University

Jilin University

Fudan University

Wuhan University

Sun Yat-sen University

Universite de Paris

Deemed University

Auckland University

The University of Tokyo

Korea University
- 2-Hydroxybenzylamine
Catalog No.:BCN1803
CAS No.:932-30-9
- PPQ-102
Catalog No.:BCC5248
CAS No.:931706-15-9
- IOX2(Glycine)
Catalog No.:BCC2229
CAS No.:931398-72-0
- Tacalcitol monohydrate
Catalog No.:BCC1976
CAS No.:93129-94-3
- (R,E)-Deca-2-ene-4,6-diyne-1,8-diol
Catalog No.:BCN4476
CAS No.:931116-24-4
- (S,E)-Deca-2,9-diene-4,6-diyne-1,8-diol
Catalog No.:BCN1305
CAS No.:931114-98-6
- Ciprofloxacin hydrochloride
Catalog No.:BCC8915
CAS No.:93107-08-5
- Enrofloxacin
Catalog No.:BCC4657
CAS No.:93106-60-6
- Kaempferol 3-sophoroside-7-rhamnoside
Catalog No.:BCN1306
CAS No.:93098-79-4
- 8-O-Demethyl-7-O-methyl-3,9-dihydropunctatin
Catalog No.:BCN1307
CAS No.:93078-83-2
- R 59-022
Catalog No.:BCC7279
CAS No.:93076-89-2
- Isosalvianolic Acid B
Catalog No.:BCC8330
CAS No.:930573-88-9
- Cistanoside A
Catalog No.:BCN2668
CAS No.:93236-42-1
- Boc-β-iodo-Ala-OMe
Catalog No.:BCC3052
CAS No.:93267-04-0
- CDDO-EA
Catalog No.:BCC5282
CAS No.:932730-51-3
- (±)-PPCC oxalate
Catalog No.:BCC7796
CAS No.:932736-91-9
- Iodoacetyl-LC-Biotin
Catalog No.:BCC3584
CAS No.:93285-75-7
- Monomethyl lithospermate
Catalog No.:BCN8124
CAS No.:933054-33-2
- 20-Hydroxy-3-oxo-28-lupanoic acid
Catalog No.:BCN4478
CAS No.:93372-87-3
- (+)-Taddol
Catalog No.:BCC8378
CAS No.:93379-49-8
- (S)-(-)-Atenolol
Catalog No.:BCC6633
CAS No.:93379-54-5
- 8-Epicrepiside E
Catalog No.:BCN7098
CAS No.:93395-30-3
- 8beta-(2-Hydroxy-2-methyl-3-oxobutyryloxy)glucozaluzanin C
Catalog No.:BCN6682
CAS No.:93395-31-4
- 2-Aminobenzimidazole
Catalog No.:BCC8547
CAS No.:934-32-7
1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues - Novel Inhibitors of Human Adenovirus Replication.[Pubmed:30116616]
Acta Naturae. 2018 Apr-Jun;10(2):58-64.
Adenovirus infections are characterized by widespread distribution. The lack of causal therapy, which is effective in treating this group of diseases, explains the need for new therapeutic drugs. Notably, anti-adenoviral activity of [4-(phenoxy)benzyl]-5-(phenylamino)-6-azauracil, 1-[4-(phenoxy)benzyl]-5-(morpholino) uracil, 1-[4-(4-chlorophenoxy)benzyl]-5-(morpholino) uracil, and 1-[4-(4-fluorophenoxy)-benzyl]-5-(morpholino) uracil was observed.